Cynthia Clayton
Plus aucun poste en cours
Profil
Ms. Cynthia Clayton is VP-Investor Relations & Corporate Communications at Alnylam Pharmaceuticals, Inc.
Ms. Clayton was previously employed as a Manager-Investor & Corporate Communications by Synta Pharmaceuticals Corp., a Principal by Curis, Inc., and Senior Manager-Investor & Corporate Communications by Millennium Pharmaceuticals, Inc.
She received her undergraduate degree from the University of Hartford.
Anciens postes connus de Cynthia Clayton
| Sociétés | Poste | Fin |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | - |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Public Communications Contact | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Public Communications Contact | - |
| ALNYLAM PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formation de Cynthia Clayton
| University of Hartford | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
